Literature DB >> 22566346

Defining progressive stages in the commitment process leading to embryonic lens formation.

Hong Jin1, Marilyn Fisher, Robert M Grainger.   

Abstract

The commitment of regions of the embryo to form particular tissues or organs is a central concept in development, but the mechanisms controlling this process remain elusive. The well-studied model of lens induction is ideal for dissecting key phases of the commitment process. We find in Xenopus tropicalis, at the time of specification of the lens, i.e., when presumptive lens ectoderm (PLE) can be isolated, cultured, and will differentiate into a lens that the PLE is not yet irreversibly committed, or determined, to form a lens. When transplanted into the posterior of a host embryo lens development is prevented at this stage, while ~ 3 h later, using the same assay, determination is complete. Interestingly, we find that specified lens ectoderm, when cultured, acquires the ability to become determined without further tissue interactions. Furthermore, we show that specified PLE has a different gene expression pattern than determined PLE, and that determined PLE can maintain expression of essential regulatory genes (e.g., foxe3, mafB) in an ectopic environment, while specified PLE cannot. These observations set the stage for a detailed mechanistic study of the genes and signals controlling tissue commitment.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566346      PMCID: PMC3870160          DOI: 10.1002/dvg.22038

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  27 in total

1.  The Wnt/beta-catenin pathway posteriorizes neural tissue in Xenopus by an indirect mechanism requiring FGF signalling.

Authors:  P M Domingos; N Itasaki; C M Jones; S Mercurio; M G Sargent; J C Smith; R Krumlauf
Journal:  Dev Biol       Date:  2001-11-01       Impact factor: 3.582

2.  Distinct roles of maf genes during Xenopus lens development.

Authors:  S Ishibashi; K Yasuda
Journal:  Mech Dev       Date:  2001-03       Impact factor: 1.882

3.  An early requirement for FGF signalling in the acquisition of neural cell fate in the chick embryo.

Authors:  S I Wilson; E Graziano; R Harland; T M Jessell; T Edlund
Journal:  Curr Biol       Date:  2000-04-20       Impact factor: 10.834

4.  Progressive determination during formation of the anteroposterior axis in Xenopus laevis.

Authors:  H L Sive; K Hattori; H Weintraub
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

5.  Early tissue interactions leading to embryonic lens formation in Xenopus laevis.

Authors:  J J Henry; R M Grainger
Journal:  Dev Biol       Date:  1990-09       Impact factor: 3.582

Review 6.  Xenopus, the next generation: X. tropicalis genetics and genomics.

Authors:  Nicolas Hirsch; Lyle B Zimmerman; Robert M Grainger
Journal:  Dev Dyn       Date:  2002-12       Impact factor: 3.780

7.  Staging of the commitment of murine cardiac cell progenitors.

Authors:  G Auda-Boucher; B Bernard; J Fontaine-Pérus; T Rouaud; M Mericksay; M F Gardahaut
Journal:  Dev Biol       Date:  2000-09-01       Impact factor: 3.582

8.  Specification and determination of limb identity: evidence for inhibitory regulation of Tbx gene expression.

Authors:  Daisuke Saito; Sayuri Yonei-Tamura; Kohko Kano; Hiroyuki Ide; Koji Tamura
Journal:  Development       Date:  2002-01       Impact factor: 6.868

9.  A morphogen gradient of Wnt/beta-catenin signalling regulates anteroposterior neural patterning in Xenopus.

Authors:  C Kiecker; C Niehrs
Journal:  Development       Date:  2001-11       Impact factor: 6.868

10.  A novel fork head gene mediates early steps during Xenopus lens formation.

Authors:  K L Kenyon; S A Moody; M Jamrich
Journal:  Development       Date:  1999-11       Impact factor: 6.868

View more
  1 in total

1.  A remarkable career in science-Joseph G. Gall.

Authors:  Sharyn A Endow; Zehra F Nizami; Susan A Gerbi
Journal:  Chromosome Res       Date:  2013-07-05       Impact factor: 5.239

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.